Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amarin: Vascepa Growth Moderates, But Long-Term Liquidity Still Appears Fine
Amarin: Vascepa Growth Moderates, But Long-Term Liquidity Still Appears Fine
Amarin: Vascepa Growth Moderates, But Long-Term Liquidity Still Appears Fine
Submitted by
admin
on April 19, 2015 - 11:52am
Source:
Seeking Alpha
News Tags:
Amarin
Vascepa
Headline:
Amarin: Vascepa Growth Moderates, But Long-Term Liquidity Still Appears Fine
Do Not Allow Advertisers to Use My Personal information
